MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 196 participants.
Also called NCT07632157
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 196 participants
- Registry
-
NCT07632157
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07632157. Randomized; double masking; primary purpose treatment. Start 2026-11-10 (actual); primary completion 2028-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation
- Acronym
- MAGNETIC-AF
- Condition
- Atrial Flutter With Rapid Ventricular Response
- Intervention (Drug)
- Magnesium Sulfate 2g
- Intervention (Drug)
- Magnesium Sulfate 4g
- Intervention (Drug)
- Saline (0.9% NaCl)
- Lead sponsor
- Wake Forest University Health Sciences
Record details
- Record id
cardio:ct-nct07632157- Content hash
d5b5336d1ade84172fb47abea628f26a32455501eb35b8bc0708bfcdee06933a